These Combined Biomarkers Help Identify Melanomas at Low Risk of Metastasis
The combined biomarkers, AMBRA1 and loricrin can be used to reliably stratify stage I and II melanomas at genuine low risk of progression.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Melanoma |
The combined biomarkers, AMBRA1 and loricrin can be used to reliably stratify stage I and II melanomas at genuine low risk of progression.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Covid 19 |
This research aims to improve the understanding of how maternal antibodies against SARS-CoV-2 are transferred to and persist in newborns.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Covid 19, POC Rapid Assays |
Sekisui formalized an exclusive distribution agreement with Aptitude Medical Systems to sell the Aptitude Metrix COVID Test in the U.S.
Read MorePosted by Andy Lundin | Dec 28, 2023 | Kidney Disease, Standards |
The NIST released new standard reference material that uses urine to check for kidney disease and conditions that affect kidney function.
Read MorePosted by Andy Lundin | Dec 27, 2023 | Sepsis |
The Symphony System is designed to address the need for simple, reliable, rapid, near-patient sepsis testing.
Read More